The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Alongside opening the new offices, Roche Diagnostics capabilities in China have been further recognised as it has been ...

These jobs will propel the province towards being a global leader in biomanufacturing and life sciences. MISSISSAUGA, ON, Nov ...

The Executive Vice-President, Diagnostics, Africa at Roche Diagnostics, Dr. Allan Pamba stated this in a statement to ...

Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...

Wish4Life Foundation, a US-based non-government organisation (NGO) dedicated to the care of children battling with cancer, is ...

Government funding will support 250 jobs in health-care technology at a Mississauga-based company. Hoffman-La Roche Limited’s ...

On November 8, 2024, Roche Diagnostics enhanced the company's long term commitment to China's local healthcare industry, to ultimately benefit patients in China and beyond, with the opening of its ...

Kazmierczak also appreciates that flexibility. “Roche provides phenomenal work-life balance, with great benefits, making it ...

Neuron23 unveiled details around its global Phase 2 NEULARK clinical trial of NEU-411 in people with early Parkinson’s disease.